Silencing of Oncogenic KRAS by Mutant-Selective Small Interfering RNA

Oncogenic mutations in the KRAS gene are well-established drivers of cancer. While the recently developed KRASG12C inhibitors offer a targeted KRAS therapy and have shown success in the clinic, KRA...